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Periplakin regulates keratin organisation and participates in the assembly of epidermal corniﬁed
envelopes. A proteomic approach identiﬁed annexin A9 as a novel interacting partner for periplakin
N-terminus. The presence of annexin A9 in complexes with periplakin was conﬁrmed by immuno-
blotting of proteins immunoprecipitated by anti-HA or anti-annexin A9 antibodies. Both endoge-
nous and GFP-tagged annexin A9 co-localise with endogenous periplakin and transfected
periplakin N-terminus at MCF-7 cell borders and aggregate after Okadaic acid treatment. Annexin
A9 and periplakin co-localise in the epidermis and annexin A9 is up-regulated in differentiating
keratinocytes, but the epidermal annexin A9 expression does not require periplakin.
Structured summary of protein interactions:
Annexin-9 physically interacts with Periplakin by anti bait co-immunoprecipitation (View interaction)
Periplakin physically interacts withAnnexin-9 by anti tag co-immunoprecipitation (View Interaction: 1, 2)
Periplakin and Annexin-9 colocalize by ﬂuorescence microscopy (View Interaction: 1, 2, 3)
Keratin-8 and Periplakin colocalize by ﬂuorescence microscopy (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Periplakin is a member of the plakin family of cytoskeletal linker
proteins that connect intermediate ﬁlaments to actin and microtu-
bule cytokeletons and to cell adhesion junctions. Periplakin shows a
restricted tissue distribution, including both stratiﬁed and simple
epithelial tissues and the brain. In the epidermis of the skin, peripla-
kin expression is upregulated upon keratinocyte differentiation and
the protein has been shown to associate with desmosomes, cortical
actin networks and the plasma membrane surrounding desmo-
somes, while the C-terminus of the protein binds intermediate
ﬁlaments [1–3]. Notably, autoantibodies against periplakin and
other plakin family members are found in patients with paraneo-
plastic pemphigus [4,5].
During the epidermal differentiation, periplakin has a role in the
formation of corniﬁed envelopes, the covalently cross-linked rem-
nants of cells that form a key component of the epidermal barrier
[6,7]. Periplakin, together with envoplakin and involucrin, formchemical Societies. Published by E
cal and Biomedical Sciences,
nited Kingdom. Fax: +44 191
ättä).
ewcastle University, Interna-
pon Tyne, NE1 3BZ, Unitedan initial scaffold under the plasma membrane upon which a large
number of small proteins such as loricrin gets deposited and cross-
linked [7,8]. Periplakin is also a major cross-linking platform for the
ceramide lipids that replace membrane phospholipids at the stra-
tum corneum [9]. Even though periplakin gene targeted mice do
not show a barrier defect [10], the ablation of the all three scaffold
proteins, periplakin, envoplakin and involucrin, results in impaired
barrier function and immune cell inﬁltration to the epidermis [7].
The N-terminus of periplakin shares the conserved structure of
a ‘plakin box’ but lacks the canonical actin-binding domain present
in the N-terminus of some of the other family members [1].
Although the crystal structure of periplakin N-terminus has not
been solved, it is likely to contain an array of individual spectrin-
related domains that ﬂank a central SH3 domain as seen in two
other plakin family members, plectin and BPAG1 [11]. Transfection
studies have shown that the N-terminus is required for targeting of
periplakin and the dimer of periplakin and envoplakin to mem-
brane locations [2]. Increased intracellular Calcium concentration
has been suggested to play a role in the membrane targeting of
periplakin N-terminus [12] and known binding partners for the
N-terminus such as kazrin and plectin may inﬂuence the subcellu-
lar targeting of the complexes [13,14]. This said, the exact mecha-
nism of the targeting of periplakin to plasma membrane around
desmosomes and the full extent of periplakin interactions at cell
border locations has not yet been revealed.lsevier B.V. All rights reserved.
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organising functions in processes such as endocytosis, vesicle
transport and membrane targeting [15,16]. The interactions be-
tween annexins and membranes usually require Calcium ions.
The membrane-binding domain of annexins has a curved surface
that – in the presence of Calcium ions – docks onto phospholipid
membranes. Annexin family members have been shown to con-
tribute to epidermal biology. Both annexin A1 and A2 have been
detected in epidermis [17]. Annexin A1 forms complexes with
S100A11 that is involved in the differentiation pathway induced
by high Calcium levels. In addition, epidermal growth factor
(EGF) induces cleavage of annexin A1 by cathepsin D at Trp12,
resulting in a loss of interaction with S100A11 [18]. Both annexin
A1 and S100A11 are retained in corneocytes where they get
cross-linked to corniﬁed envelopes [19].
In this study we show that annexin A9 (also known as pemph-
axin), an atypical annexin family member [20,21], co-immunopre-
cipitates with the periplakin N-terminus and co-localises with
periplakin both at the lateral cell borders of simple epithelial
MCF-7 cells and in differentiating epidermal keratinocytes.
2. Materials and methods
2.1. Cell culture and transfections
Human mammary adenocarcinoma cells (MCF-7) and HaCaT
keratinocytes were maintained in Dulbecco’s minimal essential
media (DMEM Sigma, UK) supplementedwith 10% foetal calf serum
and 5% GPS (L-glutamine, glucose, penicillin, streptomycin). The
stably transfected cell lines expressing the pP1/2N construct and
control (empty vector) transfected cell lines [14], the annexin A9-
GFP construct [20], and transient transfections using Lipofectamine
[22] have been described earlier. Calcium-induced differentiation
of HaCaT cells was carried as described in [23] with a switch from
a low Calcium (0.06 mM) to high-Calcium (1.6 mM) culture med-
ium. To induce a collapse of the intermediate ﬁlament cytoskeleton,
the cells were treated with Okadaic Acid as described [22].
2.2. Immunoﬂuorescence staining and confocal microscopy
Cells were grown on coverslips, ﬁxed and blocked as described
previously [22] and tissue sections were processed and stained as
described [23]. Tissue samples from periplakin gene targeted mice
[10] and control littermates were obtained from samples collected
during the breeding programme for envoplakin/periplakin/involu-
crin triple knock-out mice [7]. The following primary antibodies
were used in this study. Periplakin, TD2 and BOCZ1 rabbit polyclo-
nals (1:100 dilution); HA-tag, mouse mAb (1:200, Abcam); keratin
8, AE3 mouse mAb (1:100 dilution); annexin A9 (1:200, Abcam)
and annexin A1 (1:200, Abcam). Alexa-ﬂuor conjugated secondary
antibodies (Invitrogen) were used as described [22]. Stained cells
were observed Zeiss LSM 510 META confocal microscope imaging
system equipped with 40X and 63X/1.10 NA lenses. Images were
collected in Multi-Track Mode and composite ﬁgures were assem-
bled in PhotoShop (Adobe).
2.3. Co-immunoprecipitation and immunoblotting
Co-immunoprecipitation of periplakin interacting proteins in
MCF-7C6-Ppl, empty vector transfected control cells and non-
transfected parental MCF-7 cells using Pro-Found Mammalian
HA-tag IP/CoIP kit (Pierce); 2-D-electrophoresis using Bio–Rad 2D
gel electrophoresis system; MALDI-TOF separation of tryptic pep-
tides (with a Voyager DE-STR, Applied Biosystems, mass spectrom-
eter) and identiﬁcation of protein using the MASCOT software havebeen described earlier [14]. 1-D separation of the immunoprecipi-
tated protein complexes was carried out with 4–12% gradient gels
(Invitrogen) followed by silver staining using Silver Snap Stain Kit
II (Pierce). Immunoprecipitation with anti-annexin and anti-
periplakin antibodies was carried out in cell-extracts that were
pre-cleared with protein-G agarose beads by incubating 1–3 ml
of protein extracts with 10 ll of antibody for 1 h at 4 C on rocking
platform and then with Protein G beads at 4 C on rocking plat-
form. The immunoprecipitated complexes were washed 3 times
in lysis buffer for 20 min at 4 C. Immunoblotting of protein ex-
tracts and immunoprecipitated protein complexes and the subse-
quent detection by enhanced chemiluminescence was performed
as described previously [14,22].
2.4. Subcellular fractioning
Cells were grown to conﬂuence on 10 cm2 dishes and extracted
using saponin as described [22]. Brieﬂy, the ﬁrst extraction (S1
fraction) was carried out with saponin buffer (0.01% w/v saponin,
10 mM Tris pH 7.5, 140 mM NaCl, 5 mM EDTA, 2 mM EGTA,
1 mM PMSF (phenyl–methyl sulphonyl ﬂuoride) and protease
inhibitor cocktail tablets (Roche) and the insoluble pellet was re-
extracted using ice-cold Triton buffer (1% v/v TritonX-100,
10 mM Tris pH 7.5, 140 mM NaCl, 5 mM EDTA, 2 mM EGTA,
1 mM PMSF and protease inhibitor cocktail) to generate the S2
fraction and the Triton-insoluble fraction P fraction. All the sample
volumes were adjusted to the same volume with 4 LSB and equal
volumes were loaded on a 4–12% bis–Tris gel (Invitrogen) for anal-
ysis by immunoblotting.
3. Results
We utilised a co-immunoprecipitation approach in a MCF-7
subclone stably expressing HA-tagged periplakin N-terminus out-
lined in our previous publication [14] to identify protein com-
plexes that contain periplakin and inﬂuence the subcellular
distribution and functions of this cytoskeletal linker protein. The
over-expressed periplakin N-terminus is targeted to lateral cell
membranes of the MCF-7 subclone and shows a dominant negative
effect by interfering with cytoskeletal organisation during epithe-
lial wound healing [14]. We chose to use simple epithelial cell sys-
tem to capture potential interacting partners involved in both
keratin organisation and epidermal corniﬁed envelope functions
of periplakin as a use of differentiating keratinocytes would have
resulted in protein cross-linking that complicates proteomic anal-
ysis and is not suitable for a co-immunoprecipitation approach.
Previously, we have demonstrated using this approach how plectin
interacts with the periplakin N-terminus [14]. To identify the most
abundant constituents of the protein complexes containing peri-
plakin and to evaluate the relative amounts of the co-immunopre-
cipitated proteins we carried out 1-dimensional gradient gel
electrophoresis of the co-immunoprecipitated proteins followed
by silver staining. A 36 kDa protein was one the most prominent
protein bands in the immunoprecipitated complexes (Fig. 1A).
Mass spectrometry of tryptic peptides identiﬁed the 36 kDa pro-
tein as annexin A9 as it yielded a Mascot score of 176 (protein
scores >77 considered signiﬁcant, p < 0.05) (Fig. 1A, B and
Supplementary Table 1). Among the other major proteins was ker-
atin 8. However, we reasoned that any intermediate ﬁlament pro-
teins were likely to be recruited to the complexes by full-length
plectin, which is another previously characterised interacting
partner for periplakin [14]. The possibility of plectin bridging
keratin 8 and the periplakin N-terminus together is likely, as the
periplakin N-terminus does not contain the IF-binding domain of
the protein.
Fig. 1. Co-immunoprecipitation of annexin A9 and periplakin. (A) Silver stained 4–12% SDS–PAGE gradient gel of protein complexes immunoprecipitated with anti-HA tag
antibodies in stably transfected cell line expressing HA-tagged periplakin N-terminus (Left hand line) or control empty vector transfected cell line (Right hand). The line
indicates the HA-tagged periplakin N-terminus and the arrow points a t a 36 kDa protein that was identiﬁed as annexin A9. (B) MS spectrum of the tryptic peptides of the
annexin A9 protein band. (C) Immunoblotting of the HA-tagged periplakin and annexin A9 in the parental MCF7 cells, Empty vector transfected control cells (EV lane) and in
the MCF7-PplN-C6 cell line. (D) Immunoprecipitation with the anti HA-tag of total protein extracts of MCF-7 cells, empty vector transfected cells and the MCF7-PplN-C6 cells
followed by immunoblotting with the anti-HA antibody for the periplakin N-terminus (top panel) or anti-annexin A9 antibody (Bottom panel). (E) Immunoprecipitation of the
MCF7 cells with anti-annexin A9 antibody or protein-G Sepharose beads only (CTRL lane) followed by immunoblotting with anti-periplakin antibody (BOCZ1). Line in the
right indicates migration of 170 kDa Molecular Weight marker.
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complexes was conﬁrmed by immunoblotting (Fig. 1C). Both the
HA-tagged periplakin N-terminus and annexin A9 were detected
in complexes immunoprecipitated with an anti-HA antibody from
the MCF7-C6 cell line whereas no annexin A9 was detected when
either an empty vector transfected control cell line or the parental
MCF-7 cell line were used for the immunoprecipitation. Notably,
annexin A9 was expressed by all the three cell lines (Fig. 1D). This
conﬁrms that annexin A9 does not interact non-speciﬁcally with
HA-antibody conjugated beads used in the IP assays. Finally, we
utilised co-immunoprecipitation of the endogenous proteins to
demonstrate that the annexin–periplakin complexes can be found
in untransfected cells as annexin A9 antibodies co-immunoprecip-itated the endogenous 195 kDa periplakin in the MCF-7 cells
(Fig. 1E).
The interaction between HA-tagged periplakin N-terminus and
annexin A9 is supported by their co-localisation of at cell borders
in conﬂuent MCF-7 C6-Ppl cells (Fig. 2 A–C). Likewise, the endog-
enous full length periplakin co-localises with annexin A9 at the
cell borders in untransfected MCF-7 cells (Fig. 2 D–F), where an-
nexin A9 occupies the lateral membranes to the same extent as
periplakin (Inserts in Fig. 2 D–F) as opposed to a restricted distri-
bution of other junctional proteins, desmoplakin and beta-catenin
[22]. Finally GFP-tagged annexin A9 co-localised with HA-tagged
periplakin at cell–cell borders of the MCF-7 clone stably transfec-
ted with the periplakin construct (Fig. 2 G–I). No other annexins
Fig. 2. Co-localisation of periplakin and annexin A9 at lateral cell membranes of MCF7 cells. (A) HA-tagged periplakin N-terminus (green channel) and (B) annexin A9 (red
channel) co-localise at cell borders of the stably transfected MCF7-PplN-C6 cell line (C). Merged panel of A and B. (D) Endogenous full-length periplakin (green channel) and
(E) annexin A9 (red channel) co-localise at cell borders of the parental MCF7 cell line. Inserts in the bottom left hand corners show X–Z confocal projection of a cell border. (F)
Merged image. (G) Transiently transfected annexin A9-GFP co-localises with (H) HA-tagged periplakin N-terminus (red channel). (I) Merged panel. (J) Annexin A1 does not
localise to lateral plasma membrane with (K) annexin A9 in MCF7 cells. (L) Merged panel. (M) AnnexinA9-GFP construct transfected into control MCF7 cells. The arrowhead
indicates localisation at the cell border between the two GFP positive cells. (N) Trasfection of GFP alone into control MCF-7 cells. Scale bar corresponds to 20 lm in all panels.
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example, annexin A1 does not show similar strong lateral mem-
brane targeting as annexin A9 in MCF-7 cells (Fig. 2 J–L). In further
control experiments, GFP-annexin A9 was also targeted to cell
borders in control MCF-7 cells (Fig. 2M) indicating that the local-
isation of the GFP fusion protein was not dependent on the over-
expression of the periplakin N-terminus, whereas GFP alone was
evenly distributed in the cells without any non-speciﬁc cell border
localisation (Fig. 2N).
Further evidence for a co-localisation of annexin A9 and peri-
plakin in the same protein complexes was obtained by studying
changes in the subcellular localisation of these proteins after a dis-
ruption of the intermediate ﬁlament cytoskeleton by Okadaic acid
(OA). Inhibition of protein phosphatases by OA results in hyperph-
oshorylation of intermediate ﬁlament proteins leading to a
disassembly of the ﬁlament network. We have previously demon-
strated how the periplakin C-terminus mediates redistribution of
the protein to clusters with the collapsing intermediate ﬁlaments
[22]. Thus, we wanted to establish, whether periplakin and annex-
in A9 stay together in the same protein complex when collapsing
the intermediate ﬁlament cytoskeleton alters the localisation of
periplakin. A 2-h long treatment of MCF7 cells results in formation
of keratin8/18 clusters that contain periplakin (Fig. 3 A–C). Like-
wise, annexin A9 and periplakin co-localise in cytoplasmic aggre-
gates in OA treated cells (Fig. 3 D–F). Furthermore, OA-treatment
causes a change in the distribution of annexin A9 during subcellu-Fig. 3. Co-localisation of periplakin and annexin A9 in Okadaic acid–treated cells. (A) Ke
aggregates in MCF7 cell treated for 2 h with Okadaic acid. (C) Merged panel. (D) Cytoplasm
Merged panel. (G) Okadaic-acid treatment re-distributes all annexin A9 into the saponi
treatment and fractionation.lar fractionation, so that the protein is more abundant in the solu-
ble cytoplasmic fraction (Fig. 3G). This is in accordance with our
previously published results that show increased solubility of peri-
plakin after OA treatments [22]. The increase presence of keratin 8
in the soluble pool (Fig. 3 G) acts as a positive control for the OA
treatment.
One of the major functional roles of periplakin is the formation
of the initial sub-plasma membrane scaffold for the corniﬁed cell
envelope assembly during the acquisition of the epidermal barrier.
Likewise several annexin family members have previously been
implicated in the differentiation of the epidermal keratinocytes.
Therefore we next investigated the localisation of annexin A9
expression in skin. We found that annexin A9 co-localises with
periplakin in both interfollicular epidermis and in hair follicles of
both newborn and adult mouse skin (Fig. 4 A). In the interfollicular
epidermis the most striking co-localisation was seen at the cell
borders of differentiating, ﬂattened keratinocytes. Prominent
co-localisation was also seen in the hair follicle (Fig. 4 A). As the
staining intensity of annexin A9 seemed to increase upon keratino-
cyte differentiation, we investigated the corresponding protein lev-
els in cultured HaCaT keratinocytes following Calcium-induced
differentiation. The expression level of annexin A9 was markedly
increased within 24 h of switch to High Calcium culture medium
(Fig. 4 B) indicating either increased annexin A9 gene expression
or protein stability in differentiating keratinocytes. Intriguingly,
also the subcellular distribution of the protein was altered. Inratin 8 (red channel) and (B) periplakin (green channel) co-localise in cytoplasmic
ic aggregates of periplakin (red channel) and (E) annexin A9 in OA treated cells. (F)
n-soluble cytoplasmic fraction. Keratin 8 immunoblot was used as a control for OA
Fig. 4. Annexin A9 expression in epidermal keratinocytes. (A) annexin A9 (green channel) and periplakin (red channel) immunoﬂuorescence in adult and newborn mouse
skin. Dapi staining was used to visualise the nuclei. The stratum corneum staining in the Newborn mouse skin panel is due to non-speciﬁc binding of the secondary antibody.
Inserts in the bottom corners of annexin A, periplakin and merged panels show higher magniﬁcation of the epidermal staining. (B) Annexin A9 immunoblotting of HaCaT cells
induced to differentiate by a switch to high Calcium culture media for the indicated times. Keratin blotting (Pan-K) shows protein loading. Relative annexin A9 expression
levels compared to the low Calcium culture and normalised with the keratin expression are shown below. (C) Subcellular distribution of annexin A9 in HaCaT Cells grown in
either high or low calcium culture media. Keratin 14 immunoblot was used as a control for the fractionation. S1, cytosolic fraction; S2, Triton soluble fraction; P3 Triton-
insoluble fraction. (D). Annexin A9 expression in control (Left) and periplakin knock-out (Right) mouse skin. Inserts in the bottom right hand corners show epidermis in
higher magniﬁcation and the white dotted line indicates the dermo-epidermal junction.
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tracted from the cytoplasm of HaCaT cells whereas after the induc-
tion of the differentiation annexin A9 is mostly localised in the
Triton-insoluble membrane and cytoskeletal fraction (Fig. 4 C). Un-
like after OA-treatment, this change in subcellular distribution is
not linked to altered solubility of intermediate ﬁlaments as keratin
14 remains in insoluble cytoskeletal pool in both low and high Cal-
cium culture conditions. However, the expression of annexin A9 in
mouse epidermis does not require periplakin as the expression le-
vel and distribution of annexin A9 was not altered in periplakin-
ablated adult mouse backskin (Fig. 4 D).
4. Discussion
We demonstrate in this paper that annexin A9 is found in pro-
tein complexes containing periplakin, a cytoskeletal linker protein
belonging to the plakin family. We identiﬁed annexin A9 in a pro-
teomic screen of protein complexes co-immunoprecipitated from
MCF-7 cells stably transfected with HA-tagged periplakin N-termi-
nus. The interaction was conﬁrmed by co-immunoprecipitation of
full-length endogenous proteins and by co-localisation of the pro-
teins at cell borders of MCF-7 cells and in mouse epidermis. Thissaid, the results do not exclude the possibility that other, uncharac-
terised proteins present in the complexes mediate the interaction.
The co-localisation with annexin-A9 reveals an additional layer
of complexity of periplakin interactions at cell borders in simple
and stratiﬁed epithelia. Previously, it has been shown to participate
in the initial scaffold for corniﬁed envelope assembly together with
envoplakin and involucrin [1–3,6–8]. However, the periplakin N-
terminus appears to have several possible direct and indirect inter-
action partners. Kazrins, a group of at least ﬁve alternatively
spliced isoforms that participate in desmosome assembly and epi-
dermal differentiation also bind periplakin N-terminus but can be
targeted to at least some subcellular locations (such as acetylated
microtubules) independently on periplakin [13,24,25]. Plectin, a
large multifunctional cytolinker protein can also be found in pro-
tein complexes containing periplakin and both of these plakin pro-
teins inﬂuence keratin organisation and cell migration [14]. Taken
together, these previous ﬁndings and the novel interaction de-
scribed here indicate that the protein complexes involved in the
initial assembly of corniﬁed envelopes are likely to involve more
than the three initially suggested components.
Interestingly, both periplakin and annexin A9 are targets of
autoantibodies in epidermal blistering diseases. The linker domain
3096 V. Boczonadi, A. Määttä / FEBS Letters 586 (2012) 3090–3096of periplakin (and other plakin family member) is recognised by
autoantibodies in paraneoplastic pemphigus 5,6] whereas annexin
A9 is one of several targets in addition to well-characterised
desmoglein autoantibodies in Pemphigus Vulgaris [21].
Previous studies on annexin A9 have indicated that it differs
from other annexin family members in its response to Calcium.
At 1 mM Calcium concentration where the other annexins show
a complete or near complete association with liposomes, annexin-
A9 demonstrated only a negligible binding. Only at 2.5 mM Ca did
annexin A9 co-pellet with liposomes, but the interaction was not
reversible upon chelation of calcium but the release required addi-
tion of triton X100 to the complexes [20]. Furthermore unlike its
closest relative, annexin A2, ANXA9 was not able to bind
S100A10 in overlay assays [20]. It would be interesting to investi-
gate whether annexin A9 and periplakin are preferentially targeted
to some membrane microdomains, but it should be noted that
eventually in differentiating keratinocytes plasma membrane lip-
ids are replaced by ceramide lipids [6,9].
Our ﬁnding that annexin A9 is found in complexes with peripla-
kin provides a possible mechanism to regulate the subcellular tar-
geting of either of these two proteins. The N-terminal domain of
periplakin is required for membrane targeting both in simple epi-
thelial cells and in keratinocytes [14,22] although there is some
cell speciﬁcity in the exact requirement for targeting as the ﬁrst
16 amino acids are required for membrane association in keratino-
cytes [13] but dispensable in simple epithelial MCF-7 cells [14]. As
annexin A9 is present in periplakin null mouse epidermis, it ap-
pears that annexin A9 is targeted to membrane locations indepen-
dently of periplakin. This can, importantly, provide a mechanism
for the initial assembly of the corniﬁed envelopes. So far, none of
the previously identiﬁed periplakin interactions does explain,
how the periplakin-dependent scaffold is assembled at the plasma
membrane surrounding and between desmosomes. Further exper-
iments, for example generation of annexin A9 null mice will ad-
dress the question whether annexin A9 has a direct and unique
role in targeting or tethering periplakin to plasma membrane.
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